XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

1
Player Avatar BuffetsMentor (< 20) Submitted: 2/18/2010 1:47:33 PM : Outperform Start Price: $6.66 XNPT Score: -31.23

bizzounce

Featured Broker Partners


Advertisement